Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI111374

Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring.

S Derry, W G Wood, M Pippard, J B Clegg, D J Weatherall, S N Wickramasinghe, J Darley, S Fucharoen, and P Wasi

Find articles by Derry, S. in: PubMed | Google Scholar

Find articles by Wood, W. in: PubMed | Google Scholar

Find articles by Pippard, M. in: PubMed | Google Scholar

Find articles by Clegg, J. in: PubMed | Google Scholar

Find articles by Weatherall, D. in: PubMed | Google Scholar

Find articles by Wickramasinghe, S. in: PubMed | Google Scholar

Find articles by Darley, J. in: PubMed | Google Scholar

Find articles by Fucharoen, S. in: PubMed | Google Scholar

Find articles by Wasi, P. in: PubMed | Google Scholar

Published June 1, 1984 - More info

Published in Volume 73, Issue 6 on June 1, 1984
J Clin Invest. 1984;73(6):1673–1682. https://doi.org/10.1172/JCI111374.
© 1984 The American Society for Clinical Investigation
Published June 1, 1984 - Version history
View PDF
Abstract

The elongated alpha-globin chains of hemoglobin Constant Spring (alpha cs chain of HbCS ) are produced in low amounts such that the alpha cs-gene acts as a form of alpha-thalassemia; yet in the homozygous state the pathophysiological effects of this mutant are more severe than in the corresponding conditions that result from alpha-globin gene deletions. In studies designed to examine this discrepancy, we have demonstrated that a significant proportion of red cells produced in an HbCS homozygote has a much reduced red cell life span. Contrary to previous reports, we have been able to demonstrate the expected deficit in alpha-chain production in this condition and have shown that both the cessation of globin chain synthesis in vitro and the destruction of the excess beta-chains occur unusually rapidly. Comparison with various deletion forms of alpha-thalassemia suggests that, in terms of intracellular globin chain precipitates and free beta-chain pool, homozygous HbCS red cells more closely resemble those of HbH disease, with three of the four alpha-genes inactivated, than they do the more comparable alpha-thalassemia carriers with only two genes deleted.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1673
page 1673
icon of scanned page 1674
page 1674
icon of scanned page 1675
page 1675
icon of scanned page 1676
page 1676
icon of scanned page 1677
page 1677
icon of scanned page 1678
page 1678
icon of scanned page 1679
page 1679
icon of scanned page 1680
page 1680
icon of scanned page 1681
page 1681
icon of scanned page 1682
page 1682
Version history
  • Version 1 (June 1, 1984): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts